Fig. 2From: Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched studyUnadjusted survival curves of all patients by treatment with triweekly XELOX vs. capecitabine. a Unadjusted analysis of distant metastasis-free survival; b Unadjusted analysis of overall survival; c Unadjusted analysis of disease-free survivalBack to article page